Schroder Investment Management Group
JNP

Schroder Investment Management Group’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Schroder Investment Management Group’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14
Closed -$83 – 1537
2014
Q3 		$83 Buy
+14
New +$85 ﹤0.01% 1435

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Schroder Investment Management Group's JNP Position: Q4 2014 in Review

Schroder Investment Management Group sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2014, closing a stake of 14 shares — an estimated $83 sold.

Schroder Investment Management Group first reported a position in JNP in Q3 2014 and held it in 1 quarter. The position peaked at $83 in Q3 2014. 37 funds tracked by Wall St. Rank hold JNP as of Q4 2014.

  • Schroder Investment Management Group reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Schroder Investment Management Group sold 14 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2014, an estimated $83.
  • Schroder Investment Management Group first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2014 and held it in 1 quarter.
  • Schroder Investment Management Group's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $83 in Q3 2014.
  • 37 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2014.

Based on Schroder Investment Management Group's 13F filing for Q4 2014, filed 17 Feb 2015.